Trial Profile
Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jun 2023
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 06 Jun 2023 Status changed from active, no longer recruiting to recruiting.
- 12 May 2022 Status changed from recruiting to active, no longer recruiting.
- 12 Mar 2020 Status changed to recruiting.